Biogen announced the appointment of Chuck Triano as Senior Vice President, Head of Investor Relations effective 10 April 2023. Triano will report to Michael McDonnell, Executive Vice President and Chief Financial Officer. Mr. Triano brings over 35 years of financial experience to the role, having held executive positions across prominent biotechnology and pharmaceutical companies over the last two decades, most recently as Chief Financial Officer for Xalud Therapeutics.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BIIB:
- Biogen Appoints Chuck Triano as Head of Investor Relations
- Biogen ‘welcomes’ VHA recent decision to provide coverage to Leqembi
- VA to widely cover new Alzheimer’s treatment from Eisai and Biogen, STAT says
- Biogen price target raised to $350 from $335 at RBC Capital
- Needham healthcare analyst to hold an analyst/industry conference call
